...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Message: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

Good Endpoints article on Biogen.


Also, forgive my perpetuation of confusion. Biogen's Aducanumab and BAN2401 are two separate drugs that both tackle amyloid. I previously implied that they were one and the same.


New Message
Please login to post a reply